FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry and represents ophthalmic composition for relieving, treating or preventing a dry eye disorder comprising cyclosporine and trehalose as active ingredients, wherein weight ratio of cyclosporine:trehalose is equal to 1:20–200 and cyclosporine is present in amount of more than 0.01 wt. % to less than 1 wt. %, and trehalose is present in amount of more than 1 wt. % to 7.5 wt. % of calculation of total weight of composition.
EFFECT: invention provides a synergetic effect on preventing, relieving and treating dry eyes.
9 cl, 7 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE FORM OF CYCLOSPORINE A, METHODS FOR PREPARATION AND METHODS FOR USE THEREOF | 2012 |
|
RU2602062C2 |
| OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
| CYCLOSPORINE SUSPENSIONS A OF FORM 2 | 2012 |
|
RU2641963C2 |
| OPHTHALMIC COMPOSITIONS FOR TREATING DRY EYE SYNDROME | 2019 |
|
RU2828769C2 |
| ARTIFICIAL TEARS AND THERAPEUTIC APPLICATION | 2010 |
|
RU2589837C2 |
| COMPOSITION OF PROLONGED ACTION OF CYCLOSPORIN OF FORM 2 | 2012 |
|
RU2639393C2 |
| AQUEOUS OPHTHALMIC SOLUTION BASED ON CYCLOSPORIN A | 2013 |
|
RU2634267C2 |
| ORAL PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF "DRY EYE" SYNDROME CONTAINING REBAMIPID OR ITS PRECURSOR | 2014 |
|
RU2632107C2 |
| VITAMIN D MICROEMULSIONS AND THEIR APPLICATIONS | 2019 |
|
RU2812079C2 |
| COMPOSITION FOR EFFECTIVE LIPID DELIVERY TO HUMAN TEAR FILM USING SALT-SENSITIVE EMULSION SYSTEM | 2012 |
|
RU2772357C2 |
